The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder

References

• Edinger JD, Means MK, Carney CE, et al. Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia. Sleep. 2008 May 1;31:591-2.
   Google Scholar
• Martin SA, Aikens JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004;8:63-72
   PubMed Web of Science ®Google Scholar
• Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22(Suppl. 2):S386-93
   PubMed Web of Science ®Google Scholar
• Stoller MK. Economic effects of insomnia. Clin Ther 1994;16:873-97; discussion 854
   PubMed Web of Science ®Google Scholar
• NIH State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults statement. J Clin Sleep Med 2005;1:412-21
   Google Scholar
• Buysse DJ, Reynolds CF 3rd, Kupfer DJ, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICDS), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994;17:630-7
   PubMed Web of Science ®Google Scholar
• National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:1049-57
   Google Scholar
• Ford DE, Kamerow DB, Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 1989;262:1479-84
   PubMed Web of Science ®Google Scholar
• Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73
   PubMed Web of Science ®Google Scholar
• Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999;22(Suppl.2):S394-401
   Google Scholar
• Johnson LC, Spinweber CL. Good and poor sleepers differ in Navy performance. Mil Med 1983;148:727-31
   PubMed Web of Science ®Google Scholar
• Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia. An overview. Pharmacoeconomics 1996;10(Suppl. 1):1-14
   PubMedGoogle Scholar
• Godet-Cayre V, Pelletier-Fleury N, Le Vaillant M, et al. Insomnia and absenteeism at work. Who pays the cost? Sleep 2006;29:179-84
   PubMed Web of Science ®Google Scholar
• Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep 2006;29:299-305
   PubMed Web of Science ®Google Scholar
• Daley MD, Morin CM, LeBlance, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32:55-64
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5
   PubMed Web of Science ®Google Scholar
• Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008;31:489
   PubMed Web of Science ®Google Scholar
• Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatr 2006;59:1052-60
   PubMed Web of Science ®Google Scholar
• Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol Clin Exp 1998;13:191-8
   Web of Science ®Google Scholar
• Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal depressed non-insomniacs and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:249-60
   PubMed Web of Science ®Google Scholar
• Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999;60(Suppl. 17):28-31
   PubMed Web of Science ®Google Scholar
• Morlock RJ, Tan M, Mitchell DY. Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of the National Ambulatory Medical Survey data, 1997-2002. Clin Ther 2006;28:1044-53
   PubMed Web of Science ®Google Scholar
• Roehrs T, Roth T. ‘Hypnotic’ prescription patterns in a large managed-care population. Sleep Med 2004;5:463-6
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 1996;49:1429-33
   PubMed Web of Science ®Google Scholar
• Ashcraft ML, Fries BE, Nerenz DR, et al. A psychiatric patient classification system. An alternative to diagnosis-related groups. Med Care 1989 May;27:543-57
   PubMed Web of Science ®Google Scholar
• Fitzmaurice GM, Laird NM, Ware JW. Applied Longitudinal Modeling. Hoboken, NJ: John Wiley & Sons, 2004: 291-321
   Google Scholar
• Ozminkowski RJ, Wang S, Walsh JK, The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73
   PubMed Web of Science ®Google Scholar
• Simon G, Ormel J, VonKorff M, et al. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:352-7
   PubMed Web of Science ®Google Scholar